在早期痴呆症中提供息治疗
Karen de Sola-Smith1, Joni Gilissen2, Jenny T van der Steen3
1Department of Geriatrics (K.d.S.), Palliative and Extended Care, Veterans Affairs Medical Center, San Francisco, California, USA; Department of Physiological Nursing (K.d.S., L.J.H.), University of California San Francisco, California, USA.
Journal of pain and symptom management
|June 7, 2024
概括
在痴呆症的早期需要息护理,甚至在诊断之前. 在了解患者需求和早期痴呆症护理的有效干预方面存在研究差距.
科学领域:
- 老年学是一门学科.
- 神经学 神经学
- 抚慰性护理是一种缓解性护理.
背景情况:
- 建议所有患有痴呆症的人都接受息治疗.
- 然而,对于早期痴呆症阶段,息护理的需求和有效因素尚未明确定义.
研究的目的:
- 系统地绘制有关痴呆早期缓和护理的当前研究.
- 确定缓和护理需求和早期痴呆症的有效因素.
主要方法:
- 科学文献的范围审查. 科学文献的范围审查.
- 搜索了PubMed,CINAHL,EMBASE,Cochrane,PsycINFO,以及科学网. 这是一个很大的问题.
- 包括过去十年的英语研究,重点关注早期痴呆症的息护理.
主要成果:
- 很少有研究专门针对早期痴呆症的息护理.
- 从诊断开始就存在息护理需求,在"临界点"就有机会.
- 需求包括未来的护理倡导,保证,规划和提供者关系;有效的元素包括痴呆症特定讨论,支持网络和定制护理.
结论:
- 关于早期痴呆症息护理的文献稀少.
- 未来的研究应该集中在评估工具,患者/家庭需求和提供者/家庭培训上.
- 优化息护理时间和沟通对于早期痴呆症至关重要.
相关概念视频
Continuing Care
1.5K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.5K
Dementia
110
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
110
Alzheimer's Disease: Treatment
179
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
179
Alzheimer's Disease: Overview
462
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
462
Documentation in Long-Term and Home Healthcare Setting
880
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
880
Parkinson's Disease: Treatment
257
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
257


